Related Experiment Videos

A 61-year-old man with Parkinson's disease

¹Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA.

|March 6, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Nature aging·2026

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017

Clinical approaches to the development of a neuroprotective therapy for PD.

Experimental neurology·2017

Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.

Neurobiology of disease·2015

Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction.

Experimental neurology·2009

Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

European journal of neurology·2009

See all related articles